Background {#Sec1}
==========

The health benefits of physical activity (PA) in older adults have been well documented with reports of significant reductions in morbidity and mortality from physical and mental health problems \[[@CR1]\]. There is potential financial gain from increasing PA at a population level, with possible savings of £0.9 billion for the National Health Service (NHS) if physical activity targets are met \[[@CR2]\]. It has been suggested that brief advice on PA should target the older population (\>50y) as this has been shown to be more cost effective \[[@CR3]\]. The Chief Medical Officer recommendations for PA \[[@CR1]\] are reported in the 2013 NICE (National Institute for Clinical Excellence) guidelines for PA activity in adults which recommends a minimum of either ≥150 min of moderate to vigorous physical activity (MVPA) or ≥75 mins of vigorous physical activity (VPA) per week and suggests using the General Practice Physical Activity Questionnaire (GPPAQ) to identify those not meeting the guidelines, who would benefit from a brief PA intervention \[[@CR4]\].

The GPPAQ is a relatively new addition to general practice and is used as a brief measure of PA in patients aged 16--74 years. It is designed to take less than one minute to complete and it groups subjects into 4 categories: inactive, moderately inactive, moderately active and active. It is either self-administered or completed with a healthcare professional and designed to form a basis for discussion and motivational interviewing for anyone who scores less than 'active' (*i.e.* assumed not to be meeting PA guidelines \[[@CR4]\]). GPPAQ was commissioned by the Department of Health in 2006, developed by the London School of Hygiene and Tropical Medicine (LSHTM) \[[@CR5]\] and it forms part of the NHS Health Checks, a routine check of cardiovascular health in general practice \[[@CR6]\]. GPPAQ was included in the 2013/14 hypertension Quality and Outcomes Framework (QOF) (a pay for performance system for United Kingdom general practitioners) to incentivise the recording of PA and PA interventions, as discussed in the 'Let's get moving' commissioning document \[[@CR7]\]. It is derived from the short PA questionnaire used in the European Prospective Investigation into Cancer (EPIC) \[[@CR8]\]. The LSHTM study to assess validity of GPPAQ took place in four UK GP (General Practitioner) practices with 334 patients aged 18--74 years (of whom only 43 were aged 65--74). Two hundred fifty eight completed a second GPPAQ questionnaire a week later and an unknown proportion wore Actigraph Motion sensors (accelerometers) for validation, (data unpublished). The NHS document on GPPAQ \[[@CR5]\] refers to this validation work stating that GPPAQ has good face and construct validity and reliability and relates criterion validity to the original EPIC \[[@CR9]\] study, however we were unable to find any published GPPAQ reliability or validity data.

GPPAQ scoring is limited to questions about occupation, cycling and sport. Retired or non-working respondents who do not do a sport or cycle cannot ever be classed as "active" and will always apparently warrant a PA intervention. Questions about walking and walking pace are included, but not scored in GPPAQ, although as scoring is done automatically by many GP computer systems, practitioners may not be directly aware of this. As walking is the main PA in older adults \[[@CR10]\], this has implications for the validity of GPPAQ in this group. This has been highlighted as a concern of GPs in the 'My Best Move' Project \[[@CR11]\] and discussed in the House of Lords Science and Technology Committee \[[@CR12]\]. The 2013 NICE guidelines for PA acknowledged GPs' concerns about GPPAQ but concluded that it would continue to support its use as it is a validated tool, but encouraged further studies \[[@CR4]\]. GPPAQ remains a recommended tool in the NHS health check \[[@CR6]\] but has been removed from the general practice 2014/15 hypertension QOF \[[@CR13]\].

The PACE-Lift walking intervention trial measured PA using GPPAQ and objective accelerometer PA assessment in 60--74 year old primary care patients \[[@CR14]\]. This paper uses PACE-lift trial data to address the following aims: to assess the reliability (repeatability) and validity of GPPAQ as a tool for measuring PA levels in 60--74 year olds using accelerometry as an objective comparator; to compare reliability of GPPAQ recorded routinely in primary care with trial GPPAQ recording; and to determine the effects of retirement status and inclusion of brisk walking on GPPAQ's validity.

Methods {#Sec2}
=======

PACE-Lift trial methods {#Sec3}
-----------------------

The PACE-Lift trial aimed to increase PA, particularly walking at moderate intensity, in older primary care patients (60--74 years) from three Berkshire and Oxfordshire UK practices using a complex intervention including pedometer, accelerometer, diary, nurse consultation and behaviour change techniques \[[@CR14]\]. The trial had good recruitment for a PA intervention (298/988, 30 %) and participants wore the accelerometer on a belt around their waist, above their hip, for 7 days from rising in the morning until retiring to bed (excluding bathing or swimming) prior to completing GPPAQ at baseline (which asks about PA over the last 7 days). They were then randomly allocated into control and intervention groups. Both groups had accelerometry and GPPAQ repeated at three and twelve months (again, covering identical 7 day periods). Figure [1](#Fig1){ref-type="fig"} shows the two study arms and PA data collection points.Fig. 1Modified from PACE-Lift Protocol \[[@CR14]\]. All participants wore an accelerometer for 7 days and completed the GPPAQ questionnaire at each time point (baseline, 3 months and 12 months)

Physical activity assessment in PACE-Lift {#Sec4}
-----------------------------------------

i)Objective assessment

The Actigraph GT3X+ accelerometer records acceleration in 3 axes \[[@CR15]\]. ActiGraph data were reduced using Actilife software set to derive 5 s epochs and to ignore runs of ≥60 min of zero counts \[[@CR14], [@CR16]\]. Only days with ≥540 min of wear time were included. The summary variables for the analysis were: counts per minute (CPM); time spent in at least moderate-to-vigorous PA (MVPA) (≥1952 CPM) and time spent in vigorous PA (VPA) (≥5725 CPM) levels using standard Freedson cut-point \[[@CR17]\] and time spent in ≥10-min bouts of MVPA or VPA; we allowed for two minutes interruption (when CPA fell below the MVPA threshold) before the bout was deemed to have ended. This is the recommended default setting in the Actilife software. We used accelerometer data to categorise whether an individual achieved the PA guidelines (≥150 min of MVPA or ≥75 min of VPA, both in ≥10 min bouts, weekly) \[[@CR4]\]. Accelerometry overcomes both recall and reporting bias and indicates whether moderate to vigorous intensity PA (MVPA) is accrued in bouts of ≥ 10 min, thus giving more accurate estimates of adherence to guidelines than self-report \[[@CR18]\]. Accelerometry was used as the criterion method and it has been used successfully previously in older people with the same or very similar cut-points for MVPA and VPA \[[@CR16], [@CR18]--[@CR20]\].ii)Self-report questionnaire

The GPPAQ is a short self-report questionnaire on PA and occupation and is scored into active, moderately active, moderately inactive or inactive categories \[[@CR5]\]. Active is taken as consistent with achieving PA guidelines relating to time spent in MVPA or VPA; all other categories require a PA intervention \[[@CR5]\]. The GPPAQ questionnaire is included as an additional file [1](#MOESM1){ref-type="media"} and Fig. [2](#Fig2){ref-type="fig"} describes the scoring algorithm for GPPAQ.Fig. 2Summary of the GPPAQ Physical Activity Index Scoring \[[@CR5]\]

GPPAQ scores from computerised primary care records {#Sec5}
---------------------------------------------------

As part of the trial, consent was sought to download information from participants' computerised primary care records for the 12 month period of trial follow-up. If participants had a GPPAQ score recorded in their records during this time, as part of their routine care, it was downloaded (*n* = 56).

Ethical review {#Sec6}
--------------

The PACE-Lift trial was approved by Oxfordshire Research Ethics Committee C, UK (11/H0606/2), this approval gave permission for researchers from St George's University of London to access the trial data. Written individual informed consent was obtained before trial procedures were performed.

GPPAQ study methods {#Sec7}
-------------------

### Reliability (repeatability) {#Sec8}

The GPPAQ scores for each participant in the control group (in whom PA levels were not anticipated to change) were taken at baseline and three months and checked for agreement (n = 126). Baseline and 12 month GPPAQ scores were also compared to remove effects of seasonal variation (*n* = 129). GPPAQ scores from participants' computerised primary care records (*n* = 56) were compared to PACE-Lift trial recorded GPPAQ scores, using trial data closest in time to the primary care record. For reliability, we have shown agreement for the two different time periods. We have also calculated the weighted kappa statistic for the four-category PA index from the baseline and follow-up questionnaires using an identical approach to that used in EPIC \[[@CR8]\], with weights defined as 1-\[(i-j)/(k-1)\]^2^.

### Validity {#Sec9}

GPPAQ scores were divided into 'active' (considered to be achieving PA guidelines) or 'less than active' (comprising inactive, moderately inactive or moderately active). Objective accelerometry results were categorised into those meeting the guidelines (ie. achieving ≥150 min of MVPA or ≥75 min of VPA in ≥10 min bouts) classed as 'active' and the rest 'inactive'. A 2x2 table was constructed comparing GPPAQ results for all individuals at baseline with their accelerometer results as gold standard (*n* = 289), and sensitivity and specificity were calculated. Sensitivity was defined as: the ability of GPPAQ to correctly identify as active those achieving the PA guidelines as assessed by accelerometry. Specificity was defined as: the ability of GPPAQ to correctly identify as not active those not achieving the PA guidelines by accelerometry.

### GPPAQ-WALK {#Sec10}

Questionnaires from all at baseline (*n* = 289) were re-coded to include walking in the scoring (GPPAQ-WALK). GPPAQ-WALK differed from GPPAQ in that participants who reported walking at a brisk or fast pace for ≥3 h/week were also re-coded as active. This cut-off for time spent walking was chosen as it is the pre-specified cut-off on the GPPAQ questionnaire (Fig. [2](#Fig2){ref-type="fig"}) which corresponds to those who definitely self-report walking at a brisk or fast pace for long enough to achieve the PA guidelines by walking alone \[[@CR1]\]. The validity (sensitivity and specificity) of GPPAQ-WALK was then calculated as for GPPAQ.

### Effect of employment on GPPAQ validity {#Sec11}

The validity of GPPAQ at baseline in participants who were not in employment (*n* = 193) was compared to those in employment (*n* = 105) to see if this affected its sensitivity and specificity.

### Distribution of MVPA by GPPAQ score {#Sec12}

We calculated the mean weekly minutes of MVPA in 10 min bouts and the proportion achieving the recommended guidelines by the four GPPAQ and GPPAQ-WALK categories.

Results {#Sec13}
=======

Table [1](#Tab1){ref-type="table"} shows characteristics of the PACE-Lift participants. All age groups were well represented (60-64y, 65-69y and 70-74y) and approximately half the participants were men. The majority were retired, married and in good health, had low levels of chronic disease and disability and were mainly overweight or obese. The average daily wear-time was 793 min (mean), with a standard deviation of 75.7 min, median of 791 min and range of 615--1019 min.Table 1Baseline characteristics of the Pace-Lift cohort*N* = 298 n (%)Age at randomisation^1^ 60-64 years110 (37 %) 65-69 years105 (35 %) 70-74 years83 (28 %)Gender: Male138 (46 %)Retired/not in employment (GPPAQ questionnaire)193 (67 %)Marital status: married240 (81 %)General Health^2^: Very Good or Good260 (89 %)Chronic diseases^2^ None91 (31 %) 1-2178 (60 %) ≥329 (10 %)Townsend disability score^2^ None (0)204 (70 %) Mild disability (1--5)82 (28 %) Moderate or severe disability (6--18)7 (2 %)Body Mass Index: Overweight/obese (≥25 kg/m^2^)200 (67 %)Accelerometry data (mean (sd) of adjusted data^3^): Baseline step count per day7347 (2839) Total weekly minutes of moderate or vigorous physical activity (MVPA) in bouts of at least 10 min92 (108)^1^10 subjects were 75 years at randomisation, due to delays between invitation to participate and randomisation^2^Full references for General Health, Chronic Disease Score and Townsend Disability Score, are given in the trial protocol \[[@CR14]\]^3^Accelerometry data (step counts and MVPA) were adjusted for day of the week and day order of wearing the accelerometer in a multi-level model with household and participant as random effects

The average daily step-count at baseline was 7347 (sd 2839) (Table [1](#Tab1){ref-type="table"}) and the average weekly MVPA in bouts of ≥10 mins was 92 (sd 108), well below recommended guidelines.

Reliability (Table [2](#Tab2){ref-type="table"}) {#Sec14}
------------------------------------------------

Table 2Assessing the repeatability of the GPPAQ questionnaire data Pace-Lift GPPAQ at baseline, 3 months and 12 monthsGPPAQ at baselineInactiveModerately InactiveModerately activeActiveTotalRepeatabilityWeighted Kappa^1^GPPAQ at 3 months Inactive44105261 Moderately inactive655218 Moderately active1119829 Active1231218 3 month totals6218222412670/126 = 56 %0.57GPPAQ at 12 months Inactive5689376 Moderately inactive642214 Moderately active339217 Active0131822 12 month totals6516232512987/129 = 67 %0.63Pace-Lift 12 month GPPAQ and GPPAQ within 12 months extracted from GP recordsPace-Lift GPPAQ (self-administered at 12 months)InactiveModerately inactiveModerately activeActiveTotalRepeatabilityGPPAQ extracted from GP records Inactive911011 Moderately inactive31127 Moderately active30104 Active31026 Totals183342813/28 = 46 %0.241. Weighted Kappa calculated using weights (1.0, 0.8889, 0.5556, 0)

There were 148 participants in the control group at baseline and 143 at three months, 126 had the GPPAQ recorded at both time points. Table [2](#Tab2){ref-type="table"} shows that the percentage of GPPAQ scores that were the same (agreement) is 56 % (70/126) at three months (weighted kappa 0.57) and 67 % (87/129) at 12 months (weighted kappa 0.63).

Comparison of GP and trial recorded GPPAQ data {#Sec15}
----------------------------------------------

Activity levels of participants in the control arm with a GP recorded GPPAQ administered during the 12 month trial period were compared with GPPAQ recorded at 12 months as part of the study (n = 28) and showed a 46 % agreement (weighted kappa 0.24).

Validity (Table [3](#Tab3){ref-type="table"}) {#Sec16}
---------------------------------------------

Table 3Assessing the validity of GPPAQ questionnaire data using accelerometry data as the "gold standard"All *N* = 289Retired/Not working *N* = 193Working *N* = 96Baseline accelerometry Those achieving DH Physical Activity guidelines of 150 min of MVPA in 10 min bouts^1^69 (24 %)50 (26 %)19 (20 %)Baseline GPPAQ Physical Activity Index Not active:GPPAQ Inactive152 (53 %)116 (60 %)36 (38 %)GPPAQ Moderately inactive35 (12 %)18 (9 %)17 (18 %)GPPAQ Moderately active55 (19 %)29 (15 %)26 (27 %) Active:GPPAQ Active47 (16 %)30 (16 %)17 (18 %)Sensitivity of GPPAQ to identify "Active" individuals19 % (13/69)18 % (9/50)21 % (4/19)Specificity of GPPAQ to identify "Not active" individuals85 % (186/220)85 % (122/143)83 % (64/77)Baseline GPPAQ-Walk Physical Activity Index^2^ Not active:GPPAQ Inactive123 (43 %)97 (50 %)26 (27 %)GPPAQ Moderately inactive30 (10 %)15 (8 %)15 (16 %)GPPAQ Moderately active44 (15 %)20 (11 %)24 (25 %) Active:GPPAQ Active92 (32 %)61 (32 %)31 (32 %)Sensitivity of GPPAQ-walk to identify "Active" individuals39 % (27/69)40 % (20/50)37 % (7/19)Specificity of GPPAQ-walk to identify "Not active" individuals70 % (155/220)71 % (102/143)69 % (53/77)1. DH Guidelines recommend at least 150 min of MVPA in bouts of at least 10 mins2. GPPAQ-Walk additionally classifies those who walk ≥3 h per week at a "brisk" or "fast" pace as active

Two hundred eighty nine of the 298 participants at baseline had both GPPAQ scores and accelerometry. Using accelerometry to assess PA, 24 % (69/289) of participants met current guidelines, whereas only 16 % (47/289) were classed as "active" according to GPPAQ. Sensitivity of the GPPAQ was 19 % (13/69) and specificity 85 % (186/220) compared to accelerometry.

GPPAQ-WALK {#Sec17}
----------

The percentage classified as active by GPPAQ-WALK was 32 % (92/289). Including walking in the scoring changed the validity. GPPAQ-WALK had a sensitivity of 39 % (27/69) and a specificity of 70 % (155/220).

Effect of employment {#Sec18}
--------------------

Table [3](#Tab3){ref-type="table"} shows that in standard GPPAQ, sensitivity for detecting truly active subjects is marginally higher in those who are working than in those who are not in employment, 21 % vs 18 %. This is reversed in GPPAQ-Walk where sensitivity in those who work is 37 % and in those who are not in employment is 40 %.

Weekly MVPA and proportion achieving PA guidelines by GPPAQ & GPPAQ-WALK categories (Table [4](#Tab4){ref-type="table"}) {#Sec19}
------------------------------------------------------------------------------------------------------------------------

Table 4Comparison of GPPAQ questionnaire information and MVPA from accelerometryTotal weekly MVPA in 10 min boutsAchieved DH Guidelines for physical activity^1^Baseline standard GPPAQ Physical Activity IndexNMean (sd)N (%) Inactive15291 (112)36 (24 %) Moderately inactive3584 (91)8 (23 %) Moderately active5596 (111)12 (22 %) Active4799 (111)13 (28 %)Baseline standard GPPAQ-WALK Physical Activity Index^2^ Inactive12380 (97)27 (22 %) Moderately inactive3085 (93)6 (20 %) Moderately active4486 (108)9 (20 %) Active92115 (126)27 (29 %)1. DH Guidelines recommend at least 150 min of MVPA in bouts of at least 10 mins2. GPPAQ-Walk additionally classifies those who walk ≥3 h per week at a "brisk" or "fast" pace as active

Looking at mean total weekly MVPA in 10 min bouts there is no clear pattern across the four categories of standard GPPAQ. There is however a clear trend in MVPA in GPPAQ-WALK: active \> moderately active \> moderately inactive \> inactive. The difference is less clear when looking at the percentage achieving PA guidelines, where there is no clear trend in either group.

Discussion {#Sec20}
==========

Main findings {#Sec21}
-------------

GPPAQ is acceptable to older primary care patients, has reasonable reliability, particularly when repeated in the same season, with 67 % agreement in findings at 12 months. However, it has poor validity in this age group for identifying PA levels accurately, with a sensitivity of only 19 % compared to objective accelerometry PA assessment. The sensitivity was more than doubled by including brisk walking in the scoring (GPPAQ-Walk), but at the cost of a marked reduction in specificity, suggesting that modifying GPPAQ to include walking in this age group did not improve its overall performance as a screening test.

Strengths and limitations {#Sec22}
-------------------------

### Strengths {#Sec23}

This study has a large number of participants and also has an objective PA measure, accelerometry, as the criterion, with which GPPAQ was compared. Accelerometry was administered over the same 7 day period preceding the completion of GPPAQ, so the PA measurements correspond to the time period covered by the questionnaire. Evidence from average wear-time indicated that there was a high average wear-time (over 13 h per day, which covers approximately 8 am to 9 pm) and indicated that we captured a high proportion of the physical activity achieved by this population. We have repeated measures of GPPAQ at baseline, 3 months and 12 months and also from computerised primary care records, allowing comparisons over a short time period (but different season) and longer time period (but same season) as well as with data collected in different ways by different individuals. We have data on occupational status/retirement, allowing us to examine the effect of this on GPPAQ validity. We have examined the effect on validity of adding in brisk or fast walking to the GPPAQ score, as this is the primary PA in older people. The participants are primary care patients, the target group for GPPAQ, approximately half are male and they are comparable in terms of the proportion who are overweight and obese with a recent population based survey of this age group (68 % in PACE-Lift, 73 % in Health Survey England \[[@CR21]\]).

### Limitations {#Sec24}

The Actigraph GT3X+ accelerometer does not register complex movements well, consequently power sports (such as weight lifting), swimming and cycling are not accurately registered \[[@CR22]\]. However, it monitors walking, the main PA in older adults, accurately, is able to identify if PA is occurring in ≥10 min bouts, as stipulated by guidelines, is widely used in PA research \[[@CR23]\]. There are small amounts of missing GPPAQ data: (9/298 (3 %) at baseline, 31/298 (10 %) at three months and 16/298 (5 %) at twelve months). However, this is unlikely to bias analyses which are all within person comparisons. The pre-specified cut-off on time spent walking used to define GPPAQ-WALK (≥3 h weekly) was not exactly the same as those used in guidelines (2.5 h weekly), but was the nearest provided by the questionnaire. The effect of using a slightly higher, more difficult to achieve cut-off (≥3 h rather than ≥2.5 h) means that we may have underestimated the sensitivity and overestimated the specificity. However, GPPAQ-WALK already demonstrated greater sensitivity but poorer specificity than GPPAQ, so the direction of any effect of using the lower cut-off of ≥ 2.5 h would be unchanged from what we have described. The PACE-Lift trial only includes 60--74 year olds and is therefore not able to comment on GPPAQ's reliability and validity in 40--59 year olds, where its use is also promoted in NHS health checks \[[@CR6]\].

Comparison with existing literature {#Sec25}
-----------------------------------

Other studies have used correlation coefficients for questionnaire validation \[[@CR8]\]. However, this relies on arbitrary weighting decisions. We chose to present the raw data and calculate percentage agreement for reliability in addition to kappa statistics and to present sensitivity and specificity for validity (as has also been presented by others \[[@CR24]\]). The limitations of using correlation coefficients in PA questionnaire assessment have been discussed in other papers where Bland-Altman plots have been chosen instead \[[@CR25]\]. As described previously, there are no published studies with data on GPPAQ's reliability and validity, and this is the first study to assess GPPAQ against objective accelerometer assessment in a large sample of older adults. GPPAQ is derived from the EPIC PA questionnaire (EPIC-PAQ), which has been validated (good reliability, weighted kappa = 0.6, p \< 0.0001 and positive associations with objective measures of energy expenditure, p = 0.003) \[[@CR8]\]. Though GPPAQ was derived from EPIC-PAQ, it is difficult to use data on validation of EPIC-PAQ to throw light on our findings as their validation was primarily focussed on demonstrating correlations between accelerometry and their questionnaire measures, and not on the sensitivity and specificity for identifying those requiring intervention to increase PA \[[@CR26]\] \[[@CR9]\]. EPIC-PAQ relies on recall of PA over the last year whereas GPPAQ relies on recall over the preceding week, and EPIC-PAQ was validated in 50--65 year olds, whilst GPPAQ is aimed at 16--74 year olds \[[@CR5]\] and used in NHS health checks for 40--74 year olds \[[@CR6]\].

A feasibility study of GPPAQ use in patients aged 35--74 years across four Northern Ireland general practices examined 192 questionnaires and found that GPs and nurses reported it was an easy tool to assess PA levels with, although integration within routine practice was limited by time constraints and complex consultations \[[@CR27]\]. An important study limitation was the 8 % GPPAQ completion rate \[[@CR27]\].

In terms of other short PA self-report measures which could be appropriate for primary care, a systematic review of studies validating the short form of the International Physical Activity Questionnaire (IPAQ) found that it significantly overestimated PA when compared to objective measurement \[[@CR28]\]. A recent review of reliability and validity of 34 new PA questionnaires assessed their performance across age groups. In the elderly they found that although there is a reasonable reliability (median correlation coefficient 0.60-0.65 in existing questionnaires and 0.70 in the newer questionnaires) the validity was 'poor to acceptable' in the elderly (0.35-0.40 in existing and 0.41 in new questionnaires). They also identified sedentary behaviour as a difficult domain to assess using questionnaires, with poor correlation with objective measures \[[@CR29]\]. A global physical activity questionnaire that has been validated against national self-report survey data in a large study of almost 2 million patients in the US is the Exercise Vital Sign- a 2-item PA questionnaire \[[@CR30]\] but to date has not been validated against an objective PA measure or used in UK primary care.

Implications for research and practice {#Sec26}
--------------------------------------

The health benefits of PA, specifically in older adults, have been well documented and an accurate validated tool that would identify which older patients would benefit most from a PA intervention would be of great benefit in general practice. In response to GPs' concerns over GPPAQ, NICE recommended further studies. This study suggests that whilst the GPPAQ has reasonable reliability, it is not a valid tool for assessing PA levels in older adults. Our findings therefore support the retraction of GPPAQ from the hypertension QOF \[[@CR13]\] and question its continued use in NHS health checks \[[@CR6]\] for this age group. Currently while there are good cheap pedometers which, when worn on the hip measure step-counts, they do not measure physical activity intensity. Accelerometers worn on the hip, such as those used in our study, provide measures of both steps and intensity and thus of MVPA. They are however relatively expensive and a little uncomfortable to wear. Wrist worn devices offer improved wear acceptability, and potentially 24 h wear-time, and can be waterproofed. However, accelerometers worn on the hip generally do better than similar data from wrist worn accelerometers for measuring energy expenditure. Moreover, accurately identifying sedentary behaviour from a lack of wrist motion presents significant challenges \[[@CR31]\]. Nevertheless, improvements and rapid technological advances in PA measurement, including the use of smartphone applications and cheap accelerometers, are likely to provide more robust measures of PA in primary care, rather than relying on short but invalid questionnaires.

Conclusions {#Sec27}
===========

This paper using data from a primary care physical activity trial in 60--74 year olds is the first to provide published validation evidence on GPPAQ, a widely used assessment tool in NHS primary care. The reliability (repeatability) was reasonable with 67 % agreement at 12 months, but the validity was poor, with 19 % sensitivity and 85 % specificity compared to accelerometry. Overall screening performance was not improved by adding brisk walking to the GPPAQ score.

Our findings support the retraction of GPPAQ from the GP hypertension QOF and question its continued use in NHS health checks in this age group. Rapid technological advances in PA measurement, including the use of smartphone applications and cheap accelerometers, are likely to provide more robust measures of PA in primary care, rather than relying on short but invalid questionnaires. Further work is needed to identify an accurate validated tool that would identify which older patients would benefit most from a PA intervention within primary care.

Additional file {#Sec28}
===============

Additional file 1:**General practice physical activity questionnaire.** (JPEG 87 kb)
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NHS
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